• 1
    Kennelly R, Kavanagh DO, Hogan AM, et al. Oestrogen and the colon: potential mechanisms for cancer prevention. Lancet Oncol 2008; 9: 38591.
  • 2
    Barone M, Tanzi S, Lofano K, et al. Estrogens, phytoestrogens and colorectal neoproliferative lesions. Genes Nutr 2008; 3: 713.
  • 3
    Beral V, Banks E, Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 2002; 360: 9424.
  • 4
    Calle EE, Miracle-McMahill HL, Thun MJ, et al. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Natl Cancer Inst 1995; 87: 51723.
  • 5
    Clendenen TV, Koenig KL, Shore RE, et al. Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2009; 18: 27581.
  • 6
    Gunter MJ, Hoover DR, Yu H, et al. Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res 2008; 68: 32937.
  • 7
    Zervoudakis A, Strickler HD, Park Y, et al. Reproductive history and risk of colorectal cancer in postmenopausal women. J Natl Cancer Inst 2011; 103: 82634.
  • 8
    Sato R, Suzuki T, Katayose Y, et al. Steroid sulfatase and estrogen sulfotransferase in colon carcinoma: regulators of intratumoral estrogen concentrations and potent prognostic factors. Cancer Res 2009; 69: 91422.
  • 9
    Tsukamoto K, Inoue S, Hosoi T, et al. Isolation and radiation hybrid mapping of dinucleotide repeat polymorphism at the human estrogen receptor beta locus. J Hum Genet 1998; 43: 734.
  • 10
    Ogawa S, Hosoi T, Shiraki M, et al. Association of estrogen receptor beta gene polymorphism with bone mineral density. Biochem Biophys Res Commun 2000; 269: 53741.
  • 11
    Scariano JK, Simplicio SG, Montoya GD, et al. Estrogen receptor beta dinucleotide (CA) repeat polymorphism is significantly associated with bone mineral density in postmenopausal women. Calcif Tissue Int 2004; 74: 5018.
  • 12
    Shearman AM, Karasik D, Gruenthal KM, et al. Estrogen receptor beta polymorphisms are associated with bone mass in women and men: the Framingham Study. J Bone Miner Res 2004; 19: 77381.
  • 13
    Takeo C, Negishi E, Nakajima A, et al. Association of cytosine-adenine repeat polymorphism of the estrogen receptor-beta gene with menopausal symptoms. Gend Med 2005; 2: 96105.
  • 14
    Takeo C, Ugai K, Araki J, et al. Pharmacogenetics of hormone replacement therapy for climacteric symptoms. Biochem Biophys Res Commun 2008; 374: 6048.
  • 15
    Forsell C, Enmark E, Axelman K, et al. Investigations of a CA repeat in the oestrogen receptor beta gene in patients with Alzheimer's disease. Eur J Hum Genet 2001; 9: 8024.
  • 16
    Honma N, Arai T, Takubo K, et al. Oestrogen receptor-beta CA repeat polymorphism is associated with incidence of colorectal cancer among females. Histopathology 2011; 59: 21624.
  • 17
    Slattery ML, Sweeney C, Murtaugh M, et al. Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 293642.
  • 18
    Mahabir S, Baer DJ, Johnson LL, et al. Usefulness of body mass index as a sufficient adiposity measurement for sex hormone concentration associations in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2006; 15: 25027.
  • 19
    Kono S, Toyomura K, Yin G, et al. A case-control study of colorectal cancer in relation to lifestyle factors and genetic polymorphisms: design and conduct of the Fukuoka colorectal cancer study. Asian Pac J Cancer Prev 2004; 5: 393400.
  • 20
    Uchida K, Kimura Y, Shirota T, et al. Validity and reproducibility of the PC-assisted dietary interview used in the Fukuoka Colorectal Cancer Study. Asian Pac J Cancer Prev 2007; 8: 58390.
  • 21
    Isomura K, Kono S, Moore MA, et al. Physical activity and colorectal cancer: the Fukuoka Colorectal Cancer Study. Cancer Sci 2006; 97: 1099104.
  • 22
    Budhathoki S, Joshi AM, Ohnaka K, et al. Soy food and isoflavone intake and colorectal cancer risk: the Fukuoka colorectal cancer study. Scand J Gastroenterol 2011; 46: 16572.
  • 23
    Geng L, Yao Z, Yang H, et al. Association of CA repeat polymorphism in estrogen receptor beta gene with postmenopausal osteoporosis in Chinese. J Genet Genomics 2007; 34: 86876.
  • 24
    Westberg L, Baghaei F, Rosmond R, et al. Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women. J Clin Endocrinol Metab 2001; 86: 25628.
  • 25
    Moore JT, McKee DD, Slentz-Kesler K, et al. Cloning and characterization of human estrogen receptor beta isoforms. Biochem Biophys Res Commun 1998; 247: 758.
  • 26
    Jassam N, Bell SM, Speirs V, et al. Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging. Oncol Rep 2005; 14: 1721.
  • 27
    Arai T, Esaki Y, Sawabe M, et al. Hypermethylation of the hMLH1 promoter with absent hMLH1 expression in medullary-type poorly differentiated colorectal adenocarcinoma in the elderly. Mod Pathol 2004; 17: 1729.
  • 28
    Wong NA, Malcomson RD, Jodrell DI, et al. ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates. J Pathol 2005; 207: 5360.
  • 29
    Campbell PT, Cotterchio M, Dicks E, et al. Excess body weight and colorectal cancer risk in Canada: associations in subgroups of clinically defined familial risk of cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 173544.
  • 30
    Laake I, Thune I, Selmer R, et al. A prospective study of body mass index, weight change, and risk of cancer in the proximal and distal colon. Cancer Epidemiol Biomarkers Prev 2010; 19: 151122.
  • 31
    Lin J, Zhang SM, Cook NR, et al. Body mass index and risk of colorectal cancer in women (United States). Cancer Causes Control 2004; 15: 5819.
  • 32
    Slattery ML, Ballard-Barbash R, Edwards S, et al. Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control 2003; 14: 7584.
  • 33
    Reeves GK, Pirie K, Beral V, et al. Cancer incidence and mortality in relation to body mass index in the million women study: cohort study. Br Med J 2007; 335: 1134.
  • 34
    Terry PD, Miller AB, Rohan TE. Obesity and colorectal cancer risk in women. Gut 2002; 51: 1914.
  • 35
    Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007; 132: 220825.
  • 36
    Kuiper GG, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998; 139: 425263.
  • 37
    Zhu BT, Han GZ, Shim JY, et al. Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: insights into the structural determinants favoring a differential subtype binding. Endocrinology 2006; 147: 413250.